Pfizer

company

Investments

Number of Investments
Number of Lead Investments
44
19
Pfizer has made 44 investments. Their most recent investment was on Dec 21, 2022, when ORIC Pharmaceuticals, Inc raised
Date Company Name Round Money Raised Industry Lead Investor
Dec 21, 2022 ORIC Pharmaceuticals Post-IPO Equity Biotechnology Yes
Dec 1, 2022 Carrick Therapeutics Series C Biotechnology Yes
Sep 20, 2022 CytoReason Corporate Round Biopharma Yes
Jun 20, 2022 Valneva Post-IPO Equity Biotechnology Yes
Jun 14, 2022 Dren Bio Series B Biotechnology
Apr 27, 2022 Zentalis Pharmaceuticals Post-IPO Equity Biopharma Yes
Apr 26, 2022 Resistell AG Grant Medical Device Yes
Apr 5, 2022 National Eczema Association Grant Yes
Jan 18, 2022 Sema4 Post-IPO Equity Artificial Intelligence
Nov 4, 2021 The National Comprehensive Cancer Network (NCCN) Grant Health Care
Jun 30, 2021 Spero Therapeutics Post-IPO Equity Biotechnology Yes
Feb 17, 2021 Imcyse Series B Biotechnology Yes
Oct 29, 2020 LianBio Series A Biopharma
Aug 10, 2020 ESSA Pharma Post-IPO Equity Biopharma
Jul 29, 2020 Cerevel Therapeutics Post-IPO Equity Biotechnology
May 19, 2020 Amplyx Pharmaceuticals Series C Biotechnology
Apr 22, 2020 FoRx Therapeutics Seed Biotechnology
Jan 8, 2020 EvolveImmune Therapeutics Series Unknown Biotechnology Yes
Mar 20, 2019 Vivet Therapeutics Corporate Round Biopharma Yes
Feb 19, 2019 Gliknik Corporate Round Biotechnology Yes
Nov 13, 2018 NextCure Series B Biopharma
Apr 19, 2018 Allogene Therapeutics Series A Biotechnology
Apr 25, 2017 Aquinnah Pharmaceuticals Series Unknown Health Care Yes
Apr 14, 2017 Cortexyme Debt Financing Biotechnology
Feb 28, 2017 North Carolina Biotechnology Center Grant Biotechnology Yes
Feb 27, 2017 Arrakis Therapeutics Series A Biopharma
Jan 16, 2017 Amra Series Unknown Health Care Yes
Jan 5, 2017 Molecular Stethoscope Seed Biotechnology
Dec 28, 2016 DIR Technologies Funding Round Health Care Yes
Dec 21, 2016 Circle Pharma Series A Biotechnology
Apr 4, 2016 Metabomed Series A Biopharma
Jan 6, 2016 Cortexyme Series A Biotechnology Yes
Jan 6, 2016 NextCure Series A Biopharma
Jan 1, 2016 Imara Seed Biopharma
Dec 3, 2015 M-Tiba Seed Health Care
Oct 14, 2015 Protalix BioTherapeutics Post-IPO Equity Biotechnology Yes
May 11, 2015 AM Pharma Corporate Round Biopharma
Sep 22, 2014 Circle Pharma Seed Biotechnology
Apr 14, 2010 Aureon Laboratories Series D Biotechnology
Mar 5, 2010 Aureon Laboratories Series C Biotechnology
Jan 29, 2010 Merus Series B Biotechnology Yes
Sep 28, 2009 NovoCure Series Unknown Health Care
Jun 2, 2005 SuperDimension Series B Health Care
Sep 19, 2000 Ventaira Pharmaceuticals Series A Biotechnology